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Abstract Headache and endometriosis show some similar-
ities in their clinical and epidemiological features that are
probably due to the influence of female sexual hormones on
both disorders. Epidemiological studies indicate that they
are comorbid disorders. However, the nature of the
comorbidity is not known with certainty, but a likely
explanation may be common susceptibility genes. Another
possibility is that, because they both are related to pain,
increased pain sensitivity induced by one of the disorders
may lead to a higher likelihood of developing the other,
possibly mediated by nitrogen oxide or prostaglandins. A
common link to the widespread use of estroprogestins may
seem less probable. For physicians dealing with women
with either of these disorders, awareness of the comorbidity
may be helpful in the treatment of the patient.
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Introduction
From the point of view of headache science, the relation
between headache and typical “women’s” diseases like
endometriosis is interesting because many features of
headache, and migraine in particular, suggest a relation to
female hormones. From a clinical perspective, it is
important to know whether disorders are comorbid, and if
so, to investigate the mechanisms for the comorbidity
because this can have relevance for the choice of
investigations to make and throw light on the pathophys-
iology and the etiology of both of them.
Endometriosis is a common health problem for women.
Its exact prevalence is unknown because surgery is required
for its diagnosis, but it is estimated to be present in 3% to
10% of women of reproductive age and 25% to 35% of
infertile women. It often is accompanied by chronic pelvic
pain, which occurs in 15% to 24% of fertile women, and
active endometriosis is found in about 33% of women with
chronic pelvic pain [1]. The prevailing theory for the
pathogenesis of endometriosis (Sampson’s theory) posits
that viable endometrium can flow retrogradely through the
uterine tubes into the peritoneum during menstruation.
Accordant with this theory, it has been found that women
with increased exposure to menses (early menarche, short
cycle length, long menstrual bleeding, and low parity) are at
risk. However, these findings are not consistent, and it has
been objected that some of them may also be the results,
rather than the cause, of endometriosis [2￿]. A particular
problem for this “auto-transplant theory” is that it fails to
explain endometriosis in women who have never menstru-
ated [3]. Another hypothesis, also compatible with extrap-
eritoneal cysts (eg, in the lungs), is that endometriosis is
caused by small defects of embryogenesis [4].
Among the headaches, it is particularly for migraine that
a relation to sex hormones has been studied. Migraine is
especially common among fertile women, often starting
around the age of menarche and improving after menopause
[5]. About half of all women with migraine report an
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ache), though attacks exclusively in relation to menstrua-
tion (pure menstrual migraine) occur in only 5% to 8% of
women with migraine [6, 7]. Menstrual attacks seem to be
precipitated by the abrupt fall of estrogen at the end of the
luteal phase of the menstrual cycle. Although many factors
may precipitate attacks, migraine now is mostly understood
as a disorder of the brain, but vascular factors probably also
play a role in the pathogenesis.
Similar Features of Endometriosis and Headache
Although migraine and endometriosis clearly affect differ-
ent parts of the body, they share some clinical and
epidemiological features, most of which probably can be
accounted for by the influence of female sex hormones on
both disorders.
Early menarche seems to be a risk factor for both
headache [8￿] and endometriosis [2￿, 9￿]. For headache, it is
of interest that age of menarche seems to influence the
prevalence of headache, not only among adolescents but
throughout life [8￿]. Both psychological factors related to
early physical maturation, as well as physiological factors
related to higher estrogen levels or to increased estrogen
sensitivity, have been invoked to explain why headache is
more prevalent in females with early menarche. In the case
of endometriosis, if the theory of retrograde flow of
menstrual blood is true, all conditions (including early
menarche) that lead to more menstruations will give a
higher prevalence of endometriosis.
The fact that both migraine and endometriosis are related
to early menarche could indicate that one disorder causes
the other, but more likely, early menarche is a factor that
increases the risk of both. Because menstruation is almost a
prerequisite for developing endometriosis and because the
hormonal fluctuation related to menstruation is a strong
trigger for migraine attacks in women, it would seem
logical that the earlier menstruation starts, the more likely it
is that one or both disorders will develop. The relation of
both disorders to early menarche also could explain the
finding that migraine seems to start earlier in women with
endometriosis [10].
The common relation to sex hormones probably explains
similarities in relation to treatment with gonadotropin-
releasing hormone (GnRH) agonists (GnRH-a). A
Cochrane report has assessed GnRH-a to be effective
against pain associated with endometriosis [11￿]. A case
s t u d yh a ss h o w nt h a tm i g r a ine attacks abated during
treatment with a GnRH-a for endometriosis [12]. In a small
(n=5), noncontrolled, open study, treatment with GnRH-a
tended to relieve menstrual headaches also in women
without endometriosis [13]. In another study on migrai-
neurs without endometriosis, in which medical menopause
was first induced with a GnRH-a and the women then
received either estrogen add-back or placebo in a blinded
fashion, it was found that the GnRH-a with estrogen was
superior to the GnRH-a with placebo on all headaches [14].
The estrogen levels were probably stable in all patients, but
the effect was most marked in the estrogen add-back group.
It may be objected that in this study, the effect may be
caused by the estrogen as much as by the GnRH-a.
It also should be noted that headache is commonly listed
as a side effect of GnRH-a for treatment of endometriosis,
but there seems to be less headache with this treatment than
with danazol [11￿]. In general, when headache is reported
as a side effect, one often may question whether it is caused
by the drug or whether it occurs incidentally during the
drug treatment.
Comorbidity
Several studies indicate a comorbidity between headache
and endometriosis (ie, that they co-occur in the same
individual more often than what would be expected from
chance). The first study to suggest this was published in
1975. Before an operation for pelvic pain, 125 women were
asked about headache in the menstrual period. Those who,
during operation, proved to have endometriosis externa (ie,
outside the uterine cavity) had significantly more headache
than participants with pain from other causes, and headache
was almost as common as pelvic pain [15].
This relation has been confirmed in later studies. In a
case–control study, endometriosis was more common in
migraineurs than in the control patients without headache
(22 vs 9.6%, P<0.01). Among the women with migraine,
headache on 15 days per month or more occurred
significantly more often among those with than among
those without comorbid endometriosis, and headache-
related disability also was significantly higher in migrai-
neurs with endometriosis [16]. The group with migraine
and endometriosis had more comorbid conditions, not only
those that may be directly caused by endometriosis (eg,
dysmenorrhea, metrorrhagia, and infertility), but they also
had more depression, anxiety, irritable bowel syndrome,
fibromyalgia, chronic fatigue syndrome, and interstitial
cystitis. Migraineurs more often had symptoms of premen-
strual dysphoric disorder than control patients, but there
was no significant difference between the migraineurs with
or without endometriosis. This is in accordance with the
results from a small treatment study [17]s h o w i n ga
significant positive correlation between the severity of
headache and premenstrual syndrome (PMS), and the data
indicated that PMS symptoms were worsened by the
presence of headache.
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prevalence of headache among 133 women with endometri-
osis than among 166 control patients (63.9 vs 36.1%, P<
0.001). This difference only concerned migraine (38.3 vs
15.2%, P<0.01), being most marked for migraine with aura
(13.5% vs 1.2%, P< 0 . 0 0 1 ) .V i r t u a l l yn od i f f e r e n c ew a s
found with regard to tension-type headache (21 vs 22%) [10].
Mechanism for the Comorbidity
An epidemiological association between migraine and
endometriosis may represent methodological artifacts, but
there also are some potential natural and iatrogenic
mechanisms that could explain the association, which will
be consider here.
One possibility is that endometriosis may cause mi-
graine, or vice versa. Looking at the first option, it has been
demonstrated that the pain in endometriosis is related to
endometrial implants in pelvic tissue [18]. However, many
studies have failed to demonstrate a consistent relation
between the pain and the anatomy and biochemistry of the
implants. In a rat model of endometriosis, it has been
shown that the ectopic implants develop both sensory and
autonomic nerve supply, mediating the nerve impulses
through splanchnic nerves and the vagal nerve to the central
nervous system. It is suggested that the implants may lead
to central sensitization, causing an increased reaction to
afferent impulses also from healthy organs, which can
explain the relative lack of association between the
localization of implants and the pain. Conceivably, this
also may apply to sensory input from the head, decreasing
the threshold for developing head pain. This mechanism
would not be specific for endometriosis, which would be in
accordance with the findings of a prospective study of 108
women undergoing laparoscopy for pelvic pain that had
lasted at least 6 months. The prevalence of migraine was
not higher among women with endometriosis than among
those with other pelvic pain [19￿￿]. However, this theory
may not be corroborated by the finding that among patients
with endometriosis and headache, no difference was found
with regard to headache duration or frequency among
patients with mild endometriosis and patients with severe
endometriosis [10].
If increased sensitivity constitutes the link between
endometriosis and headache, this effect could be mediated
by prostaglandins or nitric oxide (NO). Prostaglandins are
thought to play a role in pain transmission and migraine
headache by decreasing noradrenergic transmission, sensi-
tizing nociceptors, and promoting neurogenic inflammation
[20, 21]. Endometriosis is associated with a significant
increase in prostaglandin production [22–24]. NO is an
important molecule in the regulation of cerebral blood flow
[25￿], but it also is involved in angiogenesis and nocicep-
tive processing, and several lines of evidence support its
role in both primary headaches [25] and endometriosis [26￿,
27]. However, no study has to date shown that there is a
direct link between prostaglandins or NO produced by the
endometrial implants and migraine attacks, so this would at
present seem highly speculative.
The reverse possibility, that migraine may somehow
cause endometriosis or at least make its detection more
likely, also should be considered. Migraineurs have been
shown to have a lower threshold for pain not only during
attacks and in the pre-attack phase [28￿], but also in the
interictal phase [29￿]. This could mean that those with
headache will suffer from more pain if they develop
endometriosis, and thus, increase the likelihood that
endometriosis is diagnosed. However, the fact that the
presence and severity of migraine does not seem to
influence the intensity of dysmenorrhea experienced by
the women with endometriosis is not in accord with this
theory [10].
Interestingly, it also has been hypothesized that migraine
may lead to endometriosis in a more direct way. This is
based on a study of 50 female migraineurs and 52 age- and
sex-matched control patients [30]. Surgically confirmed
endometriosis occurred more often in the migraine group
(30% vs 4%, P<0.001). In addition, the migraine group had
more often a history of self-reported menorrhagia (63% vs
37%), bruising, rectal bleeding, and excessive bleeding
after minor trauma (P<0.01), even after correcting for use
of oral contraceptives (OCs), hormone-replacement therapy
(HRT), and NSAIDs. It seems likely that menorrhagia and a
slight bleeding diathesis could result in an increased risk of
retrograde menstruation, which, according to Sampson’s
theory, could induce endometriosis. However, a weakness
of the study is that many patients in the migraine group had
endometriosis, making it likely that the menorrhagia can be
caused by the endometriosis, at least in some cases.
Also, the comorbidity may be explained by common
causal factors. One such factor could be the use of
estroprogestins because both headache and endometriosis
show a similar, although not identical, relation to use of
these medicines. For endometriosis, it is well established
that OCs, for instance, represent a valuable treatment option
for the disease by relieving pain and possibly preventing
the disorder [31￿, 32￿]. On the other hand, a recent meta-
analysis of 18 studies showed that there is an increased risk
of endometriosis in present and former users of OCs [33￿].
It also has been demonstrated that the use of OCs and HRT
are associated with headache [34, 35]. Therefore, one could
hypothesize that the comorbidity may be due to widespread
use of these substances. However, in spite of the positive
epidemiological association between OC use and endome-
triosis, there may not be a direct causal link. In one study,
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the reason they started with OCs. Women with endometri-
osis more often started it due to dysmenorrhoea, which was
taken as an indication that early symptoms of endometriosis
were the cause of the OC use, rather than the opposite
[31￿]. Similarly for headache, it has been discussed whether
the positive association between headache and OC use or
HRT is explained by the fact that many women use
estrogen supplements to relieve headache. Therefore, OC
use as cause of the comorbidity may be less plausible.
Genetics
An Australian study was performed in a cohort of 931
families with at least two sisters with endometriosis, using
815 independent monozygotic and 457 dizygotic female
twin pairs as control patients [36￿￿]. A significant additive
genetic correlation was found, indicating common genetic
influences to explain their co-occurrence within individuals.
Analyses to explore the direction of the causation indicated
an underlying genetic disposition common to both disor-
ders. There was no evidence that neuroticism could explain
the association. Further research is needed to detect the
exact genetic risk loci.
Somegeneticstudiessupportaroleoftheestrogenreceptor
1 gene in migraine susceptibility, although the exact variant is
not identified [37, 38]. This receptor also has been reported
to be associated with endometriosis [39, 40].
Conclusions
It seems likely that headache and endometriosis are comorbid
disorders.Themechanismforthecomorbidityisnotknown.It
could be a common pathogenetic factor, such as common
susceptibility genes, or it could be related to the fact that early
menarche is associated with both disorders. Also, increased
pain sensitivity induced by one of the disorders could make a
diagnosis ofthe other morelikely. Some observationsindicate
thatincreasedsensitivitycanberelatedtosimilaritiesinNOor
prostaglandin production. Because both are very prevalent
disorders, it may be important for the clinician dealing with
oneofthe disorders totakethe otherintoconsiderationtogive
the optimal treatment.
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